Healthcare, Regulatory and Reimbursement Landscape - Russia
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Russia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
Russia's population decreased at a CAGR of 0.1% between 2005 and 2010. As in most developed countries, the population contains a high proportion of elderly people, with approximately 13.2% of the population above the age of 65 years in 2010. The disease burden associated with this large elderly population is expected to boost growth in the pharmaceutical market, although hinder growth in the economy at the same time. Russia's pharmaceutical market is one of the fastest growing markets in the world, and was valued at approximately $18.7 billion in 2010, having grown at a CAGR of 23% from 2005. The medical device market is one of the most stable industries in the healthcare sector. The main segments in 2010 were diagnostic imaging, ophthalmic devices, cardiovascular devices, in vitro diagnostics and diabetes care devices.
The positive trends in the healthcare market can be attributed primarily to -
Large elderly population
Increased government spending
Government initiatives focusing on the prevention and management of chronic diseases
Government efforts to simplify regulatory guidelines
Increased prevalence of non-communicable diseases
The report provides information on the healthcare, regulatory and reimbursement landscape, and its scope includes -
Overview of the pharmaceutical and medical devices markets, including size, segmentation, and key drivers and barriers.
Profiles and SWOT analysis of the major players in the pharmaceutical and medical device markets.
Insightful review of the reimbursement and regulatory landscape, including details of the reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices.
A detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities for and challenges to growth in the healthcare market.
Reasons to buy
The report comprehensively covers both the pharmaceutical and the medical device markets. It will enhance your decision-making capability and allow you to -
Develop business strategies by understanding the trends shaping and driving the healthcare market in Russia.
Drive revenues by understanding the key trends, reimbursement and regulatory policies, and pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the main competitors.
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships.
Identify, understand and capitalize on the opportunities and challenges in the healthcare market.
Table of Contents
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 Report Guidance 11
3 Overview of the Pharmaceutical and Medical Device Market 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 16
3.1.3 Market Segments 18
3.1.4 Major Therapeutic Areas 19
3.1.5 Major Players 26
3.2 Medical Device Market 49
3.2.1 Market Overview 49
3.2.2 Overview of Top Five Segments 51
3.2.3 Major Players 61
3.3 Market Drivers and Barriers 81
3.3.1 Drivers 81
3.3.2 Barriers 82
4 Market Access 84
4.1 Reimbursement and Payer Landscape 84
4.1.1 Overview of Healthcare System 84
4.1.2 Reimbursement Process 86
4.1.3 Overview of Insurance Providers 88
4.1.4 Patient Share in Healthcare Spending 90
4.1.5 Drug Price Trends 91
4.1.6 Pricing Policies 91
4.2 Regulatory Landscape 91
4.2.1 Overview of Regulatory Agencies 91
4.2.2 New Drug Approval Process 92
4.2.3 New Device Approval Process 94
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 95
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 95
4.2.6 Intellectual Property Rights 96
4.2.7 Clinical Trial Regulations 96
4.2.8 Pharmaceutical Advertising Regulations 97
4.2.9 Labeling and Packaging Regulations 98
5 Country Analysis 99
5.1 Political Environment 99
5.1.1 Political Structure 99
5.1.2 Analysis of Current Political Environment 100
5.1.3 Healthcare Policy Initiatives 102
5.2 Economic Landscape 104
5.3 Economic Indicators 105
5.3.1 Gross Domestic Product 105
5.3.2 Gross National Income 108
5.3.3 Inflation 108
5.3.4 Currency Exchange Rate 112
5.3.5 Foreign Direct Investment 113
5.3.6 Foreign Exchange Reserves 114
5.3.7 Trade Balance 114
5.3.8 Government Structural Balance 117
5.3.9 Government Gross Debt 119
5.3.10 Major Industries 121
5.4 Demographics 122
5.4.1 Population 122
5.4.2 Education and Literacy 140
5.4.3 Employment 141
5.4.4 Disease Burden 144
5.5 Healthcare Infrastructure 146
5.5.1 Healthcare Facilities 146
5.5.2 Healthcare Parameters 153
5.5.3 Healthcare Personnel 161
5.6 Healthcare Expenditure 162
5.6.1 Overview 162
5.6.2 Major Components of Healthcare Spending 164
5.6.3 Share of Public and Private Sectors 165
5.6.4 Spending on Pharmaceutical R&D 166
5.7 Trade Associations 166
5.7.1 Association of Russian Pharmaceutical Manufacturers 166
5.7.2 Association of International Pharmaceutical Manufacturers 166
5.7.3 Russian Association of Pharmaceutical Marketing 166